Replies to post #83932 on Intellicell Biosciences Inc (fka SVFC)

[MB25]

Do you really think it can move to .004 with 250 bln A/S??

Not without news, and very good news at that. Some type of financing agreement that will take the burden off the common shareholder and remove him as the primary debt payer.

Any other news will be sold into and those who bought at .0002 and lower will be dumping for a few ticks stopping any run. Count on it.

The days of PR's of personnel changes and ill-defined upcoming events moving this stock are over. The share structure has become too bloated and too many shares have been dumped in the trips for that to occur. I know, I know, here I go "bashing" again...albeit with a heavy dose of realism.

[gempicker]

Yes.

I believe the 250 bil AS will be reserved for the preferred shareholders. They also expanded the preferred share count proportionally. And Dawson James has been working on a 15 million + financing deal.

The preferred shareholders may not be able to convert for 6-12 months or longer. But, IMO, the purpose of such share structure expansion is to give the preferred shareholders control. They develop treatments via INDs worth 100s of millions each and they can spin off, sell, divy these with preferred shareholders banking the most. The 250 billion is set aside in case the INDs fail or get trumped by newer tech. It gives them control over assets and patent estate.

I think this gets legs and trades up towards half a penny more or less. They then can can RM this sucker onto a higher exchange.

Remember too that there is unrealized value in the capital losses. Merge a profitable entity and the tax implications are worth 10s of millions alone. I suspect that is part of the entire re audit of the financials in order to capture all off those.

I don't think people realize how fast a story can change here. Capital funding, INDs launched, revenue building, RM plans??? Could be quite a scenario...

Can they execute? Is it already in motion?